Sharescart Research Club logo
Products
Research
Tools
About
  • Home
  • /
  • Syngene Internation
Join Channel
Consolidated Standalone

Syngene Internation.

₹616.3 -4.6 | 0.7%

Market Cap ₹24833 Cr.

Stock P/E 50

P/B 5.2

Current Price ₹616.3

Book Value ₹ 117.5

Face Value 10

52W High ₹960

Dividend Yield 0.2%

52W Low ₹ 598.6

Edit Ratio

Syngene Internation. Research see more...

Stocx User

Syngene International Ltd

Overview Inc. Year: 1993Industry: Business Support

Syngene International Ltd is a contract research enterprise. The Company is engaged in providing agreement research and manufacturing services in early-stage drug discovery and development to pharmaceutical and biotechnology companies. Its offerings consist of discovery chemistry and biology offerings, toxicology, pharmaceutical development, technique improvement/manufacture of intermediates, active pharmaceutical ingredients and bio-therapeutics. Its services consists of integrated, discovery and development offerings for novel molecular entities (NMEs) across commercial sectors, such as pharmaceutical, biopharmaceutical and biotechnology, amongst others. It specializes in undertaking discovery (from hit to candidate selection), development (together with pre-scientific and clinical studies, analytical and bio-analytical evaluation, and stability studies) and manufacturing (scale-up, pre-clinical and manufacturing components). It serves customers ranging from multinational agencies to start-ups.

Read More..

Syngene Internation. Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Syngene Internation. Quarterly Results

#(Fig in Cr.) Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Net Sales 808 910 854 917 790 891 944 1018 875 911
Other Income 24 22 29 16 18 21 20 19 18 15
Total Income 832 932 883 933 808 912 964 1037 892 926
Total Expenditure 596 656 622 600 620 651 662 674 668 711
Operating Profit 236 276 261 333 188 261 302 363 224 215
Interest 11 13 11 13 12 13 12 16 12 13
Depreciation 102 105 108 111 107 111 109 106 111 117
Exceptional Income / Expenses 0 -7 -4 0 32 0 0 0 0 0
Profit Before Tax 123 151 138 209 101 137 181 241 101 85
Provision for Tax 30 34 27 20 26 31 50 57 15 18
Profit After Tax 93 117 112 189 76 106 131 183 87 67
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 93 117 112 189 76 106 131 183 87 67
Adjusted Earnings Per Share 2.3 2.9 2.8 4.7 1.9 2.6 3.3 4.6 2.2 1.7

Syngene Internation. Profit & Loss

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 1423 1826 2012 2184 2604 3193 3489 3642 3748
Other Income 136 76 96 83 108 73 91 72 72
Total Income 1559 1902 2108 2268 2713 3266 3579 3714 3819
Total Expenditure 1033 1290 1409 1531 1864 2260 2474 2601 2715
Operating Profit 527 612 700 736 849 1005 1105 1114 1104
Interest 23 32 35 28 24 45 47 53 53
Depreciation 131 164 219 275 310 367 426 433 443
Exceptional Income / Expenses 0 0 71 35 -31 0 -11 32 0
Profit Before Tax 373 415 517 469 484 594 621 660 608
Provision for Tax 67 84 105 64 89 129 111 164 140
Profit After Tax 305 332 412 405 396 464 510 496 468
Adjustments 0 0 0 0 0 0 0 0 0
Profit After Adjustments 305 332 412 405 396 464 510 496 468
Adjusted Earnings Per Share 7.6 8.3 10.3 10.1 9.9 11.6 12.7 12.3 11.8

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 4% 12% 13% 0%
Operating Profit CAGR 1% 9% 10% 0%
PAT CAGR -3% 8% 4% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -33% -0% 3% 13%
ROE Average 11% 13% 14% 16%
ROCE Average 15% 15% 15% 16%

Syngene Internation. Balance Sheet

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 1720 1968 2176 2821 3298 3618 4258 4727
Minority's Interest 0 0 0 0 0 0 0 0
Borrowings 586 347 0 512 532 489 100 0
Other Non-Current Liabilities 27 168 325 327 440 466 609 643
Total Current Liabilities 784 1129 1539 1133 1229 1188 1144 1396
Total Liabilities 3117 3612 4040 4794 5498 5761 6111 6767
Fixed Assets 1030 1337 1984 2163 2354 2619 2809 2767
Other Non-Current Assets 366 511 444 824 938 717 1343 1712
Total Current Assets 1720 1764 1613 1807 2206 2425 1959 2287
Total Assets 3117 3612 4040 4794 5498 5761 6111 6767

Syngene Internation. Cash Flow

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 235 253 165 193 323 262 90 86
Cash Flow from Operating Activities 446 630 677 701 581 824 1042 1168
Cash Flow from Investing Activities -349 -647 -428 -628 -612 -656 -496 -745
Cash Flow from Financing Activities -79 -72 -226 58 -31 -343 -551 -142
Net Cash Inflow / Outflow 18 -89 23 131 -62 -175 -5 281
Closing Cash & Cash Equivalent 253 165 193 323 262 90 86 367

Syngene Internation. Ratios

# Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 7.64 8.29 10.3 10.12 9.88 11.57 12.69 12.33
CEPS(Rs) 10.92 12.4 15.79 16.99 17.6 20.7 23.28 23.08
DPS(Rs) 0.5 0.25 0 0 1 1.25 1.25 1.25
Book NAV/Share(Rs) 42.31 48.51 53.42 68.61 80.09 88.51 104.19 115.46
Core EBITDA Margin(%) 27.44 29.34 29.99 29.9 28.43 29.18 29.05 28.49
EBIT Margin(%) 27.77 24.52 27.41 22.75 19.53 19.98 19.13 19.5
Pre Tax Margin(%) 26.18 22.75 25.69 21.48 18.6 18.57 17.78 18.05
PAT Margin (%) 21.46 18.16 20.48 18.54 15.2 14.53 14.6 13.57
Cash Profit Margin (%) 30.69 27.16 31.38 31.1 27.09 25.99 26.8 25.4
ROA(%) 9.8 9.86 10.77 9.17 7.69 8.25 8.59 7.71
ROE(%) 18.05 18.26 20.21 16.59 13.29 13.73 13.18 11.23
ROCE(%) 15.76 16.98 19.6 15.4 13.24 15.43 15.55 15.42
Receivable days 68.43 60.53 66.84 73.02 68.92 59.21 50.73 48.33
Inventory Days 22.06 12.94 6.22 7.09 16.75 29.24 29.85 19.66
Payable days -5502.04 2997.21 0 -3357.42 -4008.24 -2132.64 1652.8 6521.69
PER(x) 38.56 35.46 23.45 53.68 60.44 51.39 55.31 58.9
Price/Book(x) 6.96 6.06 4.52 7.92 7.45 6.72 6.73 6.29
Dividend Yield(%) 0.17 0.09 0 0 0.17 0.21 0.18 0.17
EV/Net Sales(x) 8.15 6.64 5 10.01 9.29 7.49 7.97 7.84
EV/Core EBITDA(x) 22.02 19.81 14.39 29.69 28.5 23.78 25.15 25.65
Net Sales Growth(%) 0 28.28 10.2 8.57 19.22 22.61 9.26 4.41
EBIT Growth(%) 0 13.28 23.19 -9.9 2.33 25.62 4.57 6.74
PAT Growth(%) 0 8.58 24.28 -1.75 -2.25 17.33 9.82 -2.71
EPS Growth(%) 0 8.58 24.28 -1.75 -2.44 17.16 9.66 -2.83
Debt/Equity(x) 0.47 0.41 0.32 0.28 0.25 0.16 0.03 0.03
Current Ratio(x) 2.2 1.56 1.05 1.59 1.8 2.04 1.71 1.64
Quick Ratio(x) 2.13 1.54 1.03 1.55 1.65 1.76 1.5 1.53
Interest Cover(x) 17.41 13.86 15.94 17.94 21.1 14.13 14.15 13.43
Total Debt/Mcap(x) 0.07 0.07 0.07 0.04 0.03 0.02 0.01 0

Syngene Internation. Shareholding Pattern

# Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 54.8 54.79 54.79 54.79 54.72 54.72 52.74 52.74 52.68 52.68
FII 23.19 23.55 21.2 20.92 20.63 20.72 20.64 19.47 16.5 16.31
DII 11.19 11.7 14.62 15.79 16.78 17.48 19.53 21.5 24.05 24.62
Public 10.82 9.95 9.38 8.49 7.86 7.07 7.09 6.29 6.77 6.38
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 13% over the last 3 years.
  • Debtor days have increased from 1652.8 to 6521.69days.
  • Stock is trading at 5.2 times its book value.
  • The company has delivered a poor profit growth of 3% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Syngene Internation. News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!